I've done me head in trying to relate the numbers to the reasons offered for the lower efficacy.
They (Placebo or other group or both?) are using a number of strategies for flu prevention which has um reduced infection, which in turn, has lowered efficacy???? Doesnt that sound oh so counter intuitive????
Ann: Phase III prophylaxis trial for CS-8958 , page-19
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)